Differentiation of Mouse Nuclear Transfer Embryonic Stem Cells into Functional Pancreatic Beta Cells.

W. Jiang,Z. Bai,D. Zhang,Y. Shi,J. Yong,S. Chen,M. Ding,H. Deng
DOI: https://doi.org/10.1007/s00125-008-1065-1
IF: 8.2
2008-01-01
Diabetologia
Abstract:AIMS/HYPOTHESIS:Therapeutic cloning has been reported to have potential in the treatment of several degenerative diseases. However, it has yet to be determined whether mouse nuclear transfer-embryonic stem cells (NT-ESCs) can be differentiated into pancreatic beta cells and used to reverse diabetes in an animal model.METHODS:We first used the somatic nuclear transfer technique to generate mouse NT-ESCs and then developed a chemically defined stepwise protocol to direct the NT-ESCs into functional pancreatic beta cells. We examined the gene expression pattern of the differentiated NT-ESCs and transplanted the NT-ESC-derived insulin-producing cells into recipient diabetic mice.RESULTS:Four mouse NT-ESC lines were first established using an improved nuclear transfer technique and insulin-producing cells were efficiently generated from NT-ESCs by mimicking pancreatic in vivo development. Most of the insulin-producing cells that we generated co-produced pancreatic and duodenal homeobox 1, but not glucagon at the final stage of this differentiation method, which differed from the insulin and glucagon co-production reported by other groups. The differentiated NT-ESCs were able to release insulin in response to glucose stimuli and normalise the blood glucose level of diabetic mice for at least 2 months.CONCLUSIONS/INTERPRETATION:These results demonstrate the potential of therapeutic cloning for cell therapy of type 1 diabetes in a mouse model.
What problem does this paper attempt to address?